Metropolitan Life Insurance Company (MetLife)’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio FURX Stock Details FURX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,998	Closed	-$185K	–	2602
2015 Q4	$185K	Hold	1,998	–	–	﹤0.01%	2318
2015 Q3	$185K	Buy	+1,998	New	+$185K	﹤0.01%	2341
2014 Q3	–	Sell	-5,551	Closed	-$589K	–	2818
2014 Q2	$589K	Hold	5,551	–	–	﹤0.01%	1720
2014 Q1	$483K	Sell	5,551 -681	-11%	-$52.6K	﹤0.01%	1831
2013 Q4	$262K	Buy	6,232 +214	+4%	+$8.8K	﹤0.01%	2282
2013 Q3	$265K	Sell	6,018 -188	-3%	-$7.78K	﹤0.01%	2208
2013 Q2	$211K	Buy	+6,206	New	+$218K	﹤0.01%	2320

Metropolitan Life Insurance Company (MetLife)'s FURX Position: Q1 2016 in Review

Metropolitan Life Insurance Company (MetLife) sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q1 2016, closing a stake of 1,998 shares — an estimated $185K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in FURX in Q2 2013 and held it in 7 quarters. The position peaked at $589K in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q1 2016.

Metropolitan Life Insurance Company (MetLife) reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q1 2016 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 1,998 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q1 2016, an estimated $185K.
Metropolitan Life Insurance Company (MetLife) first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 7 quarters.
Metropolitan Life Insurance Company (MetLife)'s FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $589K in Q2 2014.
0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q1 2016.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2016, filed 16 May 2016.